Compare GHRS & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHRS | AEHR |
|---|---|---|
| Founded | 2018 | 1977 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 858.8M |
| IPO Year | 2021 | 1997 |
| Metric | GHRS | AEHR |
|---|---|---|
| Price | $15.15 | $33.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | ★ $32.90 | $21.00 |
| AVG Volume (30 Days) | 248.6K | ★ 1.1M |
| Earning Date | 02-26-2026 | 01-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $53,249,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $60.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.96 |
| 52 Week Low | $7.98 | $6.27 |
| 52 Week High | $19.51 | $34.35 |
| Indicator | GHRS | AEHR |
|---|---|---|
| Relative Strength Index (RSI) | 47.80 | 66.46 |
| Support Level | $13.60 | $22.66 |
| Resistance Level | $15.88 | $27.98 |
| Average True Range (ATR) | 0.94 | 2.84 |
| MACD | -0.20 | 0.28 |
| Stochastic Oscillator | 42.46 | 76.47 |
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.